{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:12:22Z","timestamp":1770822742505,"version":"3.50.1"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2005,8,4]],"date-time":"2005-08-04T00:00:00Z","timestamp":1123113600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1038\/nrc1693","type":"journal-article","created":{"date-parts":[[2005,8,4]],"date-time":"2005-08-04T08:54:08Z","timestamp":1123145648000},"page":"735-743","source":"Crossref","is-referenced-by-count":255,"title":["Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis"],"prefix":"10.1038","volume":"5","author":[{"given":"Yihai","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,8,4]]},"reference":[{"key":"BFnrc1693_CR1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrc1041","volume":"3","author":"R Etzioni","year":"2003","unstructured":"Etzioni, R. et al. The case for early detection. Nature Rev. Cancer 3, 243\u2013252 (2003).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc1693_CR2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF02968297","volume":"11","author":"H Kuroda","year":"2004","unstructured":"Kuroda, H., Sakamoto, G., Ohnisi, K. & Itoyama, S. Clinical and pathologic features of invasive micropapillary carcinoma. Breast Cancer 11, 169\u2013174 (2004).","journal-title":"Breast Cancer"},{"key":"BFnrc1693_CR3","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1002\/cncr.2820360943","volume":"36","author":"M Moskowitz","year":"1975","unstructured":"Moskowitz, M. et al. Breast cancer screening. Preliminary report of 207 biopsies performed in 4,128 volunteer screenees. Cancer 36, 2245\u20132250 (1975).","journal-title":"Cancer"},{"key":"BFnrc1693_CR4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747\u2013752 (2000).","journal-title":"Nature"},{"key":"BFnrc1693_CR5","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.crad.2004.05.001","volume":"59","author":"GJ Porter","year":"2004","unstructured":"Porter, G. J. et al. Patterns of metastatic breast carcinoma: influence of tumour histological grade. Clin. Radiol. 59, 1094\u20131098 (2004).","journal-title":"Clin. Radiol."},{"key":"BFnrc1693_CR6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"LJ van't Veer","year":"2002","unstructured":"van't Veer, L. J. et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530\u2013536 (2002).","journal-title":"Nature"},{"key":"BFnrc1693_CR7","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1002\/1097-0142(19951215)76:12<2464::AID-CNCR2820761210>3.0.CO;2-U","volume":"76","author":"T Fujisawa","year":"1995","unstructured":"Fujisawa, T., Yamaguchi, Y., Saitoh, Y., Hiroshima, K. & Ohwada, H. Blood and lymphatic vessel invasion as prognostic factors for patients with primary resected nonsmall cell carcinoma of the lung with intrapulmonary metastases. Cancer 76, 2464\u20132470 (1995).","journal-title":"Cancer"},{"key":"BFnrc1693_CR8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ygyno.2003.09.009","volume":"92","author":"H Taubert","year":"2004","unstructured":"Taubert, H. et al. Detection of disseminated tumor cells in peripheral blood of patients with breast cancer: correlation to nodal status and occurrence of metastases: lymphogenous and hematogenous metastasis of Lewis lung carcinoma in the mouse. Gynecol. Oncol. 92, 256\u2013261 (2004).","journal-title":"Gynecol. Oncol."},{"key":"BFnrc1693_CR9","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ijc.2910400423","volume":"40","author":"L Weiss","year":"1987","unstructured":"Weiss, L. & Ward, P. M. Lymphogenous and hematogenous metastasis of Lewis lung carcinoma in the mouse. Int. J. Cancer 40, 570\u2013574 (1987).","journal-title":"Int. J. Cancer"},{"key":"BFnrc1693_CR10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2005.01.017","volume":"7","author":"MG Achen","year":"2005","unstructured":"Achen, M. G., McColl, B. K. & Stacker, S. A. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 7, 121\u2013127 (2005).","journal-title":"Cancer Cell"},{"key":"BFnrc1693_CR11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc863","volume":"2","author":"SA Stacker","year":"2002","unstructured":"Stacker, S. A., Achen, M. G., Jussila, L., Baldwin, M. E. & Alitalo, K. Lymphangiogenesis and cancer metastasis. Nature Rev. Cancer 2, 573\u2013583 (2002).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc1693_CR12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1083\/jcb.200308082","volume":"163","author":"MS Pepper","year":"2003","unstructured":"Pepper, M. S. & Skobe, M. Lymphatic endothelium: morphological, molecular and functional properties. J. Cell Biol. 163, 209\u2013213 (2003).","journal-title":"J. Cell Biol."},{"key":"BFnrc1693_CR13","first-page":"257","volume":"20","author":"MH Witte","year":"1987","unstructured":"Witte, M. H. & Witte, C. L. Lymphatics and blood vessels, lymphangiogenesis and hemangiogenesis: from cell biology to clinical medicine. Lymphology 20, 257\u2013266 (1987).","journal-title":"Lymphology"},{"key":"BFnrc1693_CR14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1083\/jcb.50.2.300","volume":"50","author":"LV Leak","year":"1971","unstructured":"Leak, L. V. Studies on the permeability of lymphatic capillaries. J. Cell Biol. 50, 300\u2013323 (1971).","journal-title":"J. Cell Biol."},{"key":"BFnrc1693_CR15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.it.2004.05.003","volume":"25","author":"P Saharinen","year":"2004","unstructured":"Saharinen, P., Tammela, T., Karkkainen, M. J. & Alitalo, K. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol. 25, 387\u2013395 (2004).","journal-title":"Trends Immunol."},{"key":"BFnrc1693_CR16","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1158\/0008-5472.CAN-04-0752","volume":"64","author":"N Isaka","year":"2004","unstructured":"Isaka, N., Padera, T. P., Hagendoorn, J., Fukumura, D. & Jain, R. K. Peritumor lymphatics induced by vascular endothelial growth factor-C exhibit abnormal function. Cancer Res. 64, 4400\u20134404 (2004).","journal-title":"Cancer Res."},{"key":"BFnrc1693_CR17","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1126\/science.1071420","volume":"296","author":"TP Padera","year":"2002","unstructured":"Padera, T. P. et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296, 1883\u20131886 (2002).","journal-title":"Science"},{"key":"BFnrc1693_CR18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF01753576","volume":"6","author":"U Kim","year":"1988","unstructured":"Kim, U., Park, H. C. & Choi, K. H. Differential permeability of lymphatic and blood vessels in determining the route of metastasis as demonstrated by indirect lymphography. Clin. Exp. Metastasis 6, 291\u2013299 (1988).","journal-title":"Clin. Exp. Metastasis"},{"key":"BFnrc1693_CR19","doi-asserted-by":"crossref","first-page":"9225","DOI":"10.1158\/0008-5472.CAN-04-2475","volume":"64","author":"K Alitalo","year":"2004","unstructured":"Alitalo, K., Mohla, S. & Ruoslahti, E. Lymphangiogenesis and cancer: meeting report. Cancer Res 64, 9225\u20139229 (2004).","journal-title":"Cancer Res"},{"key":"BFnrc1693_CR20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/84643","volume":"7","author":"M Skobe","year":"2001","unstructured":"Skobe, M. et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nature Med. 7, 192\u2013198 (2001).","journal-title":"Nature Med."},{"key":"BFnrc1693_CR21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ccr.2004.08.034","volume":"6","author":"R Cao","year":"2004","unstructured":"Cao, R. et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6, 333\u2013345 (2004).","journal-title":"Cancer Cell"},{"key":"BFnrc1693_CR22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1749-6632.2002.tb04872.x","volume":"979","author":"L Chang","year":"2002","unstructured":"Chang, L., Kaipainen, A. & Folkman, J. Lymphangiogenesis new mechanisms. Ann. NY Acad. Sci. 979, 111\u2013119 (2002).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrc1693_CR23","doi-asserted-by":"crossref","first-page":"11658","DOI":"10.1073\/pnas.0404272101","volume":"101","author":"LK Chang","year":"2004","unstructured":"Chang, L. K. et al. Dose-dependent response of FGF-2 for lymphangiogenesis. Proc. Natl Acad. Sci. USA 101, 11658\u201311663 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1693_CR24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1534-5807(02)00217-4","volume":"3","author":"NW Gale","year":"2002","unstructured":"Gale, N. W. et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1. Dev. Cell 3, 411\u2013423 (2002).","journal-title":"Dev. Cell"},{"key":"BFnrc1693_CR25","doi-asserted-by":"crossref","first-page":"8868","DOI":"10.1073\/pnas.062040199","volume":"99","author":"H Kubo","year":"2002","unstructured":"Kubo, H. et al. Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc. Natl Acad. Sci. USA 99, 8868\u20138873 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1693_CR26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S1534-5807(02)00231-9","volume":"3","author":"T Veikkola","year":"2002","unstructured":"Veikkola, T. & Alitalo, K. Dual role of Ang2 in postnatal angiogenesis and lymphangiogenesis. Dev. Cell 3, 302\u2013304 (2002).","journal-title":"Dev. Cell"},{"key":"BFnrc1693_CR27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ccr.2004.09.024","volume":"6","author":"L Vincent","year":"2004","unstructured":"Vincent, L. & Rafii, S. Vascular frontiers without borders: multifaceted roles of platelet-derived growth factor (PDGF) in supporting postnatal angiogenesis and lymphangiogenesis. Cancer Cell 6, 307\u2013309 (2004).","journal-title":"Cancer Cell"},{"key":"BFnrc1693_CR28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1126\/science.1065298","volume":"295","author":"Y Maeshima","year":"2002","unstructured":"Maeshima, Y. et al. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science 295, 140\u2013143 (2002).","journal-title":"Science"},{"key":"BFnrc1693_CR29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","volume":"79","author":"MS O'Reilly","year":"1994","unstructured":"O'Reilly, M. S. et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315\u2013328 (1994).","journal-title":"Cell"},{"key":"BFnrc1693_CR30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","volume":"88","author":"MS O'Reilly","year":"1997","unstructured":"O'Reilly, M. S. et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277\u2013285 (1997).","journal-title":"Cell"},{"key":"BFnrc1693_CR31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1, 27\u201331 (1995).","journal-title":"Nature Med."},{"key":"BFnrc1693_CR32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","volume":"86","author":"D Hanahan","year":"1996","unstructured":"Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353\u2013364 (1996).","journal-title":"Cell"},{"key":"BFnrc1693_CR33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/84635","volume":"7","author":"SA Stacker","year":"2001","unstructured":"Stacker, S. A. et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nature Med. 7, 186\u2013191 (2001).","journal-title":"Nature Med."},{"key":"BFnrc1693_CR34","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197108122850711","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl J. Med. 285, 1182\u20131186 (1971).","journal-title":"N. Engl J. Med."},{"key":"BFnrc1693_CR35","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJM199512283332608","volume":"333","author":"J Folkman","year":"1995","unstructured":"Folkman, J. Seminars in medicine of the beth israel hospital, boston. Clinical applications of research on angiogenesis. N. Engl J. Med. 333, 1757\u20131763 (1995).","journal-title":"N. Engl J. Med."},{"key":"BFnrc1693_CR36","first-page":"963","volume":"57","author":"M Relf","year":"1997","unstructured":"Relf, M. et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor \u03b2-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res. 57, 963\u2013969 (1997).","journal-title":"Cancer Res."},{"key":"BFnrc1693_CR37","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/0092-8674(91)90033-U","volume":"66","author":"J Kandel","year":"1991","unstructured":"Kandel, J. et al. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66, 1095\u20131104 (1991).","journal-title":"Cell"},{"key":"BFnrc1693_CR38","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1038\/sj.onc.1204630","volume":"20","author":"B Galy","year":"2001","unstructured":"Galy, B., Creancier, L., Prado-Lourenco, L., Prats, A. C. & Prats, H. p53 directs conformational change and translation initiation blockade of human fibroblast growth factor 2 mRNA. Oncogene 20, 4613\u20134620 (2001).","journal-title":"Oncogene"},{"key":"BFnrc1693_CR39","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/sj.onc.1204271","volume":"20","author":"B Galy","year":"2001","unstructured":"Galy, B., Creancier, L., Zanibellato, C., Prats, A. C. & Prats, H. Tumour suppressor p53 inhibits human fibroblast growth factor 2 expression by a post-transcriptional mechanism. Oncogene 20, 1669\u20131677 (2001).","journal-title":"Oncogene"},{"key":"BFnrc1693_CR40","doi-asserted-by":"crossref","first-page":"9009","DOI":"10.1073\/pnas.91.19.9009","volume":"91","author":"T Ueba","year":"1994","unstructured":"Ueba, T. et al. Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells. Proc. Natl Acad. Sci. USA 91, 9009\u20139013. (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1693_CR41","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/sj.onc.1201090","volume":"14","author":"B Enholm","year":"1997","unstructured":"Enholm, B. et al. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 14, 2475\u20132483 (1997).","journal-title":"Oncogene"},{"key":"BFnrc1693_CR42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF02639435","volume":"31","author":"RA Gjerset","year":"1995","unstructured":"Gjerset, R. A. et al. Characterization of a new human glioblastoma cell line that expresses mutant p53 and lacks activation of the PDGF pathway. In Vitro Cell. Dev. Biol. Anim. 31, 207\u2013214 (1995).","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"BFnrc1693_CR43","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1242\/jcs.01228","volume":"117","author":"H Uramoto","year":"2004","unstructured":"Uramoto, H. et al. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF \u03b2-receptor transcription. J. Cell Sci. 117, 3855\u20133865 (2004).","journal-title":"J. Cell Sci."},{"key":"BFnrc1693_CR44","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0092-8674(03)00154-5","volume":"112","author":"T Cramer","year":"2003","unstructured":"Cramer, T. et al. HIF-1\u03b1 is essential for myeloid cell-mediated inflammation. Cell 112, 645\u2013657 (2003).","journal-title":"Cell"},{"key":"BFnrc1693_CR45","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/35107085","volume":"414","author":"Y Makino","year":"2001","unstructured":"Makino, Y. et al. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 414, 550\u2013554 (2001).","journal-title":"Nature"},{"key":"BFnrc1693_CR46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/jemt.10253","volume":"60","author":"T Sano","year":"2003","unstructured":"Sano, T. & Horiguchi, H. Von Hippel\u2013Lindau disease. Microsc. Res. Tech. 60, 159\u2013164 (2003).","journal-title":"Microsc. Res. Tech."},{"key":"BFnrc1693_CR47","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1073\/pnas.94.3.861","volume":"94","author":"JL Arbiser","year":"1997","unstructured":"Arbiser, J. L. et al. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc. Natl Acad. Sci. USA 94, 861\u2013866 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1693_CR48","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1023\/A:1010619316436","volume":"46","author":"WC Su","year":"2001","unstructured":"Su, W. C. et al. Expression of oncogene products HER2\/Neu and Ras and fibrosis-related growth factors bFGF, TGF-\u03b2, and PDGF in bile from biliary malignancies and inflammatory disorders. Dig. Dis. Sci. 46, 1387\u20131392 (2001).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrc1693_CR49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1160\/TH03-04-0200","volume":"90","author":"M Lohela","year":"2003","unstructured":"Lohela, M., Saaristo, A., Veikkola, T. & Alitalo, K. Lymphangiogenic growth factors, receptors and therapies. Thromb. Haemost. 90, 167\u2013184 (2003).","journal-title":"Thromb. Haemost."},{"key":"BFnrc1693_CR50","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1093\/emboj\/cdf470","volume":"21","author":"TV Petrova","year":"2002","unstructured":"Petrova, T. V. et al. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J. 21, 4593\u20134599 (2002).","journal-title":"EMBO J."},{"key":"BFnrc1693_CR51","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/nrc1456","volume":"4","author":"CH Heldin","year":"2004","unstructured":"Heldin, C. H., Rubin, K., Pietras, K. & Ostman, A. High interstitial fluid pressure \u2014 an obstacle in cancer therapy. Nature Rev. Cancer 4, 806\u2013813 (2004).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc1693_CR52","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1126\/science.286.5449.2511","volume":"286","author":"G Thurston","year":"1999","unstructured":"Thurston, G. et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286, 2511\u20132514 (1999).","journal-title":"Science"},{"key":"BFnrc1693_CR53","first-page":"112","volume":"55","author":"WJ Cliff","year":"1970","unstructured":"Cliff, W. J. & Nicoll, P. A. Structure and function of lymphatic vessels of the bat's wing. Q. J. Exp. Physiol. Cogn. Med. Sci. 55, 112\u2013131 (1970).","journal-title":"Q. J. Exp. Physiol. Cogn. Med. Sci."},{"key":"BFnrc1693_CR54","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1084\/jem.20021244","volume":"196","author":"JA Nagy","year":"2002","unstructured":"Nagy, J. A. et al. Vascular permeability factor\/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J. Exp. Med. 196, 1497\u20131506 (2002).","journal-title":"J. Exp. Med."},{"key":"BFnrc1693_CR55","first-page":"1315","volume":"62","author":"NJ Beasley","year":"2002","unstructured":"Beasley, N. J. et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res. 62, 1315\u20131320 (2002).","journal-title":"Cancer Res."},{"key":"BFnrc1693_CR56","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4161\/cc.4.2.1419","volume":"4","author":"Y Cao","year":"2005","unstructured":"Cao, Y. Direct role of PDGF-BB in lymphangiogenesis and lymphatic metastasis. Cell Cycle 4, 228\u2013230 (2005).","journal-title":"Cell Cycle"},{"key":"BFnrc1693_CR57","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0002-9440(10)64328-3","volume":"162","author":"SS Dadras","year":"2003","unstructured":"Dadras, S. S. et al. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am. J. Pathol. 162, 1951\u20131960 (2003).","journal-title":"Am. J. Pathol."},{"key":"BFnrc1693_CR58","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1073\/pnas.95.2.548","volume":"95","author":"MG Achen","year":"1998","unstructured":"Achen, M. G. et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl Acad. Sci. USA 95, 548\u2013553 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1693_CR59","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/emboj\/20.4.672","volume":"20","author":"SJ Mandriota","year":"2001","unstructured":"Mandriota, S. J. et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 20, 672\u2013682 (2001).","journal-title":"EMBO J."},{"key":"BFnrc1693_CR60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/modpathol.3800253","volume":"18","author":"WW Choi","year":"2005","unstructured":"Choi, W. W. et al. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Mod. Pathol. 18, 143\u2013152 (2005).","journal-title":"Mod. Pathol."},{"key":"BFnrc1693_CR61","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1167\/iovs.03-1380","volume":"45","author":"C Cursiefen","year":"2004","unstructured":"Cursiefen, C. et al. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest. Ophthalmol. Vis. Sci. 45, 2666\u20132673 (2004).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BFnrc1693_CR62","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/j.1460-2075.1996.tb00359.x","volume":"15","author":"V Joukov","year":"1996","unstructured":"Joukov, V. et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15, 290\u2013298 (1996).","journal-title":"EMBO J."},{"key":"BFnrc1693_CR63","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1084\/jem.20041896","volume":"201","author":"S Hirakawa","year":"2005","unstructured":"Hirakawa, S. et al. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J. Exp. Med. 201, 1089\u20131099 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnrc1693_CR64","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2002-03-0755","volume":"101","author":"P Salven","year":"2003","unstructured":"Salven, P., Mustjoki, S., Alitalo, R., Alitalo, K. & Rafii, S. VEGFR-3 and CD133 identify a population of CD34+ lymphatic\/vascular endothelial precursor cells. Blood 101, 168\u2013172 (2003).","journal-title":"Blood"},{"key":"BFnrc1693_CR65","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1158\/0008-5472.CAN-04-0088","volume":"64","author":"Y He","year":"2004","unstructured":"He, Y. et al. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Res. 64, 3737\u20133740 (2004).","journal-title":"Cancer Res."},{"key":"BFnrc1693_CR66","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ni1013","volume":"5","author":"MJ Karkkainen","year":"2004","unstructured":"Karkkainen, M. J. et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nature Immunol. 5, 74\u201380 (2004).","journal-title":"Nature Immunol."},{"key":"BFnrc1693_CR67","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/emboj\/21.7.1505","volume":"21","author":"JT Wigle","year":"2002","unstructured":"Wigle, J. T. et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J. 21, 1505\u20131513 (2002).","journal-title":"EMBO J."},{"key":"BFnrc1693_CR68","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet, P. & Jain, R. K. Angiogenesis in cancer and other diseases. Nature 407, 249\u2013257 (2000).","journal-title":"Nature"},{"key":"BFnrc1693_CR69","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0002-9440(10)64309-X","volume":"162","author":"HF Dvorak","year":"2003","unstructured":"Dvorak, H. F. Rous-whipple award lecture. How tumors make bad blood vessels and stroma. Am. J. Pathol. 162, 1747\u20131757 (2003).","journal-title":"Am. J. Pathol."},{"key":"BFnrc1693_CR70","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1101-1194","volume":"7","author":"D Lyden","year":"2001","unstructured":"Lyden, D. et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Med. 7, 1194\u20131201 (2001).","journal-title":"Nature Med."},{"key":"BFnrc1693_CR71","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.RES.0000118600.91698.BB","volume":"94","author":"R Cao","year":"2004","unstructured":"Cao, R. et al. Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ. Res. 94, 664\u2013670 (2004).","journal-title":"Circ. Res."},{"key":"BFnrc1693_CR72","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1172\/JCI200522037","volume":"115","author":"P Baluk","year":"2005","unstructured":"Baluk, P. et al. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J. Clin. Invest. 115, 247\u2013257 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnrc1693_CR73","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI20465","volume":"113","author":"C Cursiefen","year":"2004","unstructured":"Cursiefen, C. et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest. 113, 1040\u20131050 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnrc1693_CR74","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood.V97.3.785","volume":"97","author":"A Sawano","year":"2001","unstructured":"Sawano, A. et al. Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 97, 785\u2013791 (2001).","journal-title":"Blood"},{"key":"BFnrc1693_CR75","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cytogfr.2004.03.007","volume":"15","author":"L Fredriksson","year":"2004","unstructured":"Fredriksson, L., Li, H. & Eriksson, U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev. 15, 197\u2013204 (2004).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFnrc1693_CR76","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/02841869309083897","volume":"32","author":"B Westermark","year":"1993","unstructured":"Westermark, B. & Heldin, C. H. Platelet-derived growth factor. Structure, function and implications in normal and malignant cell growth. Acta. Oncol. 32, 101\u2013105 (1993).","journal-title":"Acta. Oncol."},{"key":"BFnrc1693_CR77","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cytogfr.2004.03.005","volume":"15","author":"C Betsholtz","year":"2004","unstructured":"Betsholtz, C. Insight into the physiological functions of PDGF through genetic studies in mice. Cytokine Growth Factor Rev. 15, 215\u2013228 (2004).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFnrc1693_CR78","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1242\/dev.00721","volume":"130","author":"RV Hoch","year":"2003","unstructured":"Hoch, R. V. & Soriano, P. Roles of PDGF in animal development. Development 130, 4769\u20134784 (2003).","journal-title":"Development"},{"key":"BFnrc1693_CR79","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.277.5323.242","volume":"277","author":"P Lindahl","year":"1997","unstructured":"Lindahl, P., Johansson, B. R., Leveen, P. & Betsholtz, C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277, 242\u2013245 (1997).","journal-title":"Science"},{"key":"BFnrc1693_CR80","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0039-6060(96)80120-6","volume":"119","author":"K Anan","year":"1996","unstructured":"Anan, K. et al. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery 119, 333\u2013339 (1996).","journal-title":"Surgery"},{"key":"BFnrc1693_CR81","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/bmj.296.6637.1621","volume":"296","author":"MT Travers","year":"1988","unstructured":"Travers, M. T. et al. Growth factor expression in normal, benign, and malignant breast tissue. Br. Med. J. (Clin. Res. Ed.) 296, 1621\u20131624 (1988).","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"BFnrc1693_CR82","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-1-4419-8871-3_12","volume":"117","author":"K Lamszus","year":"2004","unstructured":"Lamszus, K., Heese, O. & Westphal, M. Angiogenesis-related growth factors in brain tumors. Cancer Treat. Res. 117, 169\u2013190 (2004).","journal-title":"Cancer Treat. Res."},{"key":"BFnrc1693_CR83","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cytogfr.2004.03.002","volume":"15","author":"A Ostman","year":"2004","unstructured":"Ostman, A. PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma. Cytokine Growth Factor Rev. 15, 275\u2013286 (2004).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFnrc1693_CR84","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1158\/0008-5472.957.65.3","volume":"65","author":"WG Roberts","year":"2005","unstructured":"Roberts, W. G. et al. Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451. Cancer Res. 65, 957\u2013966 (2005).","journal-title":"Cancer Res."},{"key":"BFnrc1693_CR85","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1126\/science.6199844","volume":"223","author":"Y Shing","year":"1984","unstructured":"Shing, Y. et al. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 223, 1296\u20131299 (1984).","journal-title":"Science"},{"key":"BFnrc1693_CR86","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1471-4914(02)02394-8","volume":"8","author":"S Javerzat","year":"2002","unstructured":"Javerzat, S., Auguste, P. & Bikfalvi, A. The role of fibroblast growth factors in vascular development. Trends Mol. Med. 8, 483\u2013489 (2002).","journal-title":"Trends Mol. Med."},{"key":"BFnrc1693_CR87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08977199009037497","volume":"3","author":"YH Cao","year":"1990","unstructured":"Cao, Y. H. & Pettersson, R. F. Human acidic fibroblast growth factor overexpressed in insect cells is not secreted into the medium. Growth Factors 3, 1\u201313 (1990).","journal-title":"Growth Factors"},{"key":"BFnrc1693_CR88","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1096\/fasebj.9.10.7542215","volume":"9","author":"RE Friesel","year":"1995","unstructured":"Friesel, R. E. & Maciag, T. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J. 9, 919\u2013925 (1995).","journal-title":"FASEB J."},{"key":"BFnrc1693_CR89","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1091\/mbc.e03-08-0589","volume":"15","author":"J Malecki","year":"2004","unstructured":"Malecki, J., Wesche, J., Skjerpen, C. S., Wiedlocha, A. & Olsnes, S. Translocation of FGF-1 and FGF-2 across vesicular membranes occurs during G1-phase by a common mechanism. Mol. Biol. Cell 15, 801\u2013814 (2004).","journal-title":"Mol. Biol. Cell"},{"key":"BFnrc1693_CR90","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1018342129279","volume":"1","author":"G Christofori","year":"1997","unstructured":"Christofori, G. & Luef, S. Novel forms of acidic fibroblast growth factor-1 are constitutively exported by b tumor cell lines independent from conventional secretion and apoptosis. Angiogenesis 1, 55\u201370 (1997).","journal-title":"Angiogenesis"},{"key":"BFnrc1693_CR91","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/jnci\/86.5.356","volume":"86","author":"M Nguyen","year":"1994","unstructured":"Nguyen, M. et al. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J. Natl Cancer Inst. 86, 356\u2013361 (1994).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrc1693_CR92","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/0470856734.ch9","volume":"256","author":"JC Tille","year":"2004","unstructured":"Tille, J. C., Nisato, R. & Pepper, M. S. Lymphangiogenesis and tumour metastasis. Novartis Found. Symp. 256, 112\u2013131 (2004).","journal-title":"Novartis Found. Symp."},{"key":"BFnrc1693_CR93","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0008-6363(03)00518-2","volume":"59","author":"J Rutanen","year":"2003","unstructured":"Rutanen, J. et al. Vascular endothelial growth factor-D expression in human atherosclerotic lesions. Cardiovasc. Res. 59, 971\u2013979 (2003).","journal-title":"Cardiovasc. Res."},{"key":"BFnrc1693_CR94","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0002-9440(10)64255-1","volume":"161","author":"SF Schoppmann","year":"2002","unstructured":"Schoppmann, S. F. et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am. J. Pathol. 161, 947\u2013956 (2002).","journal-title":"Am. J. Pathol."},{"key":"BFnrc1693_CR95","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/35025215","volume":"407","author":"GD Yancopoulos","year":"2000","unstructured":"Yancopoulos, G. D. et al. Vascular-specific growth factors and blood vessel formation. Nature 407, 242\u2013248 (2000).","journal-title":"Nature"},{"key":"BFnrc1693_CR96","doi-asserted-by":"crossref","first-page":"12677","DOI":"10.1073\/pnas.221449198","volume":"98","author":"MJ Karkkainen","year":"2001","unstructured":"Karkkainen, M. J. et al. A model for gene therapy of human hereditary lymphedema. Proc. Natl Acad. Sci. USA 98, 12677\u201312682 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1693_CR97","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1182\/blood-2004-08-3382","volume":"105","author":"T Morisada","year":"2005","unstructured":"Morisada, T. et al. Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation. Blood 105, 4649\u20134656 (2005).","journal-title":"Blood"},{"key":"BFnrc1693_CR98","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1089\/153968503768330247","volume":"1","author":"C Mouta","year":"2003","unstructured":"Mouta, C. & Heroult, M. Inflammatory triggers of lymphangiogenesis. Lymphat. Res. Biol. 1, 201\u2013218 (2003).","journal-title":"Lymphat. Res. Biol."},{"key":"BFnrc1693_CR99","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/jnci\/djh308","volume":"96","author":"CD Atkins","year":"2004","unstructured":"Atkins, C. D. Re: Influence of the new AJCC breast cancer staging system on sentinel lymph node positivity and false-negative rates. J. Natl Cancer Inst. 96, 1639 (2004).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrc1693_CR100","first-page":"641","volume":"91","author":"S Delahaye","year":"2004","unstructured":"Delahaye, S. et al. [Routine sentinel node detection in breast cancer. Experience of the Curie Institute]. Bull Cancer 91, 641\u2013647 (2004) (in French).","journal-title":"Bull Cancer"},{"key":"BFnrc1693_CR101","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1349-7006.2004.tb03166.x","volume":"95","author":"ES Nakamura","year":"2004","unstructured":"Nakamura, E. S., Koizumi, K., Kobayashi, M. & Saiki, I. Inhibition of lymphangiogenesis-related properties of murine lymphatic endothelial cells and lymph node metastasis of lung cancer by the matrix metalloproteinase inhibitor MMI270. Cancer Sci. 95, 25\u201331 (2004).","journal-title":"Cancer Sci."},{"key":"BFnrc1693_CR102","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nm848","volume":"9","author":"R Cao","year":"2003","unstructured":"Cao, R. et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nature Med. 9, 604\u2013613 (2003).","journal-title":"Nature Med."}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrc1693.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrc1693","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrc1693.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T14:21:41Z","timestamp":1706451701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrc1693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,4]]},"references-count":102,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["BFnrc1693"],"URL":"https:\/\/doi.org\/10.1038\/nrc1693","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,4]]}}}